Name: Vesugen

Alias: AEDL Tetrapeptide, Vascular Endothelial Bioregulator Peptide CAS Registry number: N/A Sequence: Ala-Glu-Asp-Leu-OH Molecular Formula: C??H??N?O? Molecular Weight: 451.44 Da Purity: ≥99% (by HPLC) Appearance: White lyophilized powder Packing: 20mg*10vials/box Product Group: Vascular endothelial epigenetic regulatory short peptide

Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.

Brief Introduction:

Vesugen is a synthetic AEDL tetrapeptide belonging to the Khavinson organ-specific bioregulator peptide family, exclusively for laboratory research. It penetrates cell and nuclear membranes to bind chromatin and regulate gene expression in vascular endothelial cells. It protects endothelial cells from oxidative stress, hyperglycemia damage and inflammatory erosion, improves vascular wall integrity and stability. It promotes microcirculation reconstruction, inhibits vascular endothelial aging and reduces endothelial fibrosis. It improves peripheral blood perfusion, delays age-related vascular sclerosis, and maintains normal vasodilation function. Widely applied in vascular endothelial protection, microcirculation repair, vascular aging, atherosclerosis mechanism and vessel-specific epigenetic peptide research.

Main Research Applications:

Vascular endothelial protection research: Used in cell and animal models to study endothelial anti-oxidation, anti-injury and barrier stabilization mechanisms. Microcirculation repair research: Suitable for exploring local blood perfusion improvement and microvessel regeneration pathways. Vascular aging & sclerosis research: Applied to investigate endothelial senescence delay and vascular stiffness reduction effects. Metabolic vascular damage research: For comparative analysis of hyperglycemia and inflammation-induced vascular lesion relief.

Organ bioregulator pharmacology research: Study chromatin-targeted gene regulation characteristics of vascular-specific short peptides.